A Japanese pharmaceutical manufacturer focused on prescription medicines for central nervous system disorders, immunology, and metabolic diseases. The company has developed treatments for conditions such as ALS and diabetes and historically operated as a core healthcare unit within Mitsubishi Chemic...
This page tracks all publicly disclosed congressional trades in Mitsubishi Tanabe Pharma (MTZPY), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-11-19 | Greg Gianforte | sell | $15K – $50K |